Guillermo C. H.
- Country
- Spain
- Department
- Medical oncology
Research Overview
- PEACE-6 Poor Responders: A randomized phase III trial evaluating the efficacy and safety of 177Lu-PSMA-617 in addition to Standard of Care (SoC) versus SoC alone in de novo metastatic hormone-sensitive prostate cancer (mHSPC) patients having a serum PSA level of ≥ 0.2 ng/mL at 6 to 8 months after systemic treatment initiation for mHSPC.
- Phase 3 Randomized Open-label Study of Opevesostat Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer
- Phase II Randomized Trial of Lutetium (177Lu) Oxodotreotide Dosing Intervals in Grade 1-2 Advanced Midgut Neuroendocrine Tumors to Assess Hematological Toxicity
Data & Insights
Has run more than one trial at 46 of 176 partner sites.
Specializations
Oncological Focus
This investigator specializes in advanced treatments for metastatic castration-resistant prostate cancer, evaluating novel therapeutic approaches in the field of urological oncology.
- Advanced prostate cancer management
- Hormone-resistant cancer therapies
- Metastatic disease treatment
The investigator's work centers on evaluating therapeutic alternatives for patients who have progressed after initial hormonal therapy.
Treatment Innovation
The investigator explores comparative therapeutic approaches in oncology, specifically examining novel agents against established treatment options for advanced prostate cancer.
- Novel therapeutic agents
- Alternative treatment pathways
- Treatment resistance solutions
Their research focuses on identifying more effective treatment options for patients with progressive disease.
Clinical Outcomes
The investigator specializes in assessing progression-free survival and overall survival outcomes in advanced prostate cancer patients.
- Survival metrics evaluation
- Disease progression assessment
- Treatment response monitoring
Their expertise includes evaluating treatment efficacy through sophisticated clinical endpoints.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.